Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeles Alvarez Secord

Showing results (71-80 of 239) with videos related to

Pageof 24
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 21, 2026
Quality-adjusted progression-free survival analysis of veliparib and carboplatin/paclitaxel compared with chemotherapy alone in patients with newly diagnosed ovarian cancer (VELIA/GOG3005): ancillary analysis of a placebo-controlled, phase 3 randomized trialJoseph Lafferty, Angeles Alvarez Secord, Michael Bookman, et al.
Gynecologic Oncology|July 12, 2011
Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinomaPatricia A Convery, Leigh A Cantrell, Nicola Di Santo, et al.
Gynecologic Oncology|June 18, 2013
Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancerWilliam J Lowery, Ashlei W Lowery, Jason C Barnett, et al.
Gynecologic Oncology|March 17, 2019
Targeted composite value-based endpoints in platinum-sensitive recurrent ovarian cancerJonathan R Foote, Angeles Alvarez Secord, Margaret I Liang, et al.
Annals of Medicine|February 11, 2023
Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinomaWesley C Burkett, Ziyi Zhao, Meredith A Newton, et al.
Gynecologic Oncology|March 23, 2006
Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study, Angeles Alvarez Secord, Paula S Lee, et al.
Gynecologic Oncology|October 24, 2017
Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancerEdward Tanner, Allison Puechl, Kimberly Levinson, et al.
Gynecologic Oncology Research and Practice|May 28, 2016
Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell linesMicael Lopez-Acevedo, Lisa Grace, Deanna Teoh, et al.
The Lancet. Gastroenterology & Hepatology|December 9, 2023
Management of malignant bowel obstruction - Authors' replyRobert S Krouse, Garnet L Anderson, Kathryn B Arnold, et al.
Gynecologic Oncology|May 19, 2009
Multicenter analysis of recurrence and survival in stage IIIA endometrial cancerLaura J Havrilesky, Angeles Alvarez Secord, David M O'Malley, et al.
Pageof 24

Showing results (71-80 of 239) with videos related to

Sort By:
Pageof 24
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 21, 2026
Quality-adjusted progression-free survival analysis of veliparib and carboplatin/paclitaxel compared with chemotherapy alone in patients with newly diagnosed ovarian cancer (VELIA/GOG3005): ancillary analysis of a placebo-controlled, phase 3 randomized trialJoseph Lafferty, Angeles Alvarez Secord, Michael Bookman, et al.
Gynecologic Oncology|July 12, 2011
Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinomaPatricia A Convery, Leigh A Cantrell, Nicola Di Santo, et al.
Gynecologic Oncology|June 18, 2013
Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancerWilliam J Lowery, Ashlei W Lowery, Jason C Barnett, et al.
Gynecologic Oncology|March 17, 2019
Targeted composite value-based endpoints in platinum-sensitive recurrent ovarian cancerJonathan R Foote, Angeles Alvarez Secord, Margaret I Liang, et al.
Annals of Medicine|February 11, 2023
Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinomaWesley C Burkett, Ziyi Zhao, Meredith A Newton, et al.
Gynecologic Oncology|March 23, 2006
Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study, Angeles Alvarez Secord, Paula S Lee, et al.
Gynecologic Oncology|October 24, 2017
Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancerEdward Tanner, Allison Puechl, Kimberly Levinson, et al.
Gynecologic Oncology Research and Practice|May 28, 2016
Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell linesMicael Lopez-Acevedo, Lisa Grace, Deanna Teoh, et al.
The Lancet. Gastroenterology & Hepatology|December 9, 2023
Management of malignant bowel obstruction - Authors' replyRobert S Krouse, Garnet L Anderson, Kathryn B Arnold, et al.
Gynecologic Oncology|May 19, 2009
Multicenter analysis of recurrence and survival in stage IIIA endometrial cancerLaura J Havrilesky, Angeles Alvarez Secord, David M O'Malley, et al.
Pageof 24